Omniseq

Omniseq company information, Employees & Contact Information

Explore related pages

Related company profiles:

OmniSeq, an innovation of Roswell Park Cancer Institute, is a molecular diagnostic laboratory based in Buffalo, New York. OmniSeq endeavors to find the right drug or the right trial for every patient by improving access to better cancer treatment options through molecular profiling. In addition to other NY State CLEP approved assays, OmniSeq offers OmniSeq Comprehensive and Immune Report Card. These two assays are available clinically in the United States and interrogate all known genomic and immune markers tied to approved therapeutics and clinical trials. OmniSeq is also making significant investments to create better diagnostics for immuno-oncology therapy selection. OmniSeq is proud to partner with pharmaceutical companies to provide research support for immuno-oncology development projects. For more information, call 1-800-781-1259 or visit www.omniseq.com.

Company Details

Employees
25
Founded
-
Address
700 Ellicott Street, Buffalo,new York 14203,united States
Phone
1(800)781-1259
Email
fi****@****seq.com
Industry
Biotechnology
HQ
Buffalo, New York
Looking for a particular Omniseq employee's phone or email?

Omniseq Questions

News

Rebecca Previs: HRD Testing Is Now Available Through OmniSeq INSIGHT - Oncodaily

Rebecca Previs: HRD Testing Is Now Available Through OmniSeq INSIGHT Oncodaily

Roswell Park Comprehensive Cancer Center Spins Out Transformative New Company – OmniSeq, LLC - Roswell Park Comprehensive Cancer Center

Roswell Park Comprehensive Cancer Center Spins Out Transformative New Company – OmniSeq, LLC Roswell Park Comprehensive Cancer Center

Labcorp And OmniSeq Launch INSIGHT℠, Next-Generation Sequencing Platform to Advance Precision Oncology - PR Newswire

Labcorp And OmniSeq Launch INSIGHT℠, Next-Generation Sequencing Platform to Advance Precision Oncology PR Newswire

Wilmot Cancer Institute Joins OmniSeq Genomic Network - University of Rochester Medical Center

Wilmot Cancer Institute Joins OmniSeq Genomic Network University of Rochester Medical Center

OmniSeq Board Names Margot Schoenborn to Succeed Mark Gardner as CEO - GlobeNewswire

OmniSeq Board Names Margot Schoenborn to Succeed Mark Gardner as CEO GlobeNewswire

LAG-3 transcriptomic expression patterns across malignancies: Implications for precision immunotherapeutics - Wiley Online Library

LAG-3 transcriptomic expression patterns across malignancies: Implications for precision immunotherapeutics Wiley Online Library

Targeted Therapy and Immune-Oncology Biomarkers in a Single Test - Inside Precision Medicine

Targeted Therapy and Immune-Oncology Biomarkers in a Single Test Inside Precision Medicine

Margot Schoenborn becomes CEO of fast-growing OmniSeq - The Business Journals

Margot Schoenborn becomes CEO of fast-growing OmniSeq The Business Journals

LAG-3 transcriptomic expression patterns across malignancies: Implications for precision immunotherapeutics - Wiley Online Library

LAG-3 transcriptomic expression patterns across malignancies: Implications for precision immunotherapeutics Wiley Online Library

The next big thing in Buffalo biotech? Answer may be OmniSeq. - The Business Journals

The next big thing in Buffalo biotech? Answer may be OmniSeq. The Business Journals

Top Omniseq Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant